BASF welcomes EU approval for zinc oxide
After BASF’s Tinosorb A2B, Z-Cote is the second nano UV filter to be approved for use in cosmetics in Europe.
BASF welcomes the official entry of zinc oxide into Annex VI of the EU Cosmetics Regulation. Zinc oxide — in both its nano and non-nano form — is now approved for use as a UV filter in cosmetics in Europe. “UV radiation is responsible for various physiological effects in the skin. These include sunburn, premature appearance of wrinkles and — with frequent intensive exposure — an increased risk of skin cancer,” said Dirk Mampe, Head of Business Management for Personal Care Specialties in Europe. “Each approval of a UV filter offers new options and a wider choice for formulators of sun care products to provide vital protection for the skin against these harmful effects of UV radiation. After the EU approval of Tinosorb A2B as the first nano UV filter in 2014, we now welcome the official entry of zinc oxide in its nano form into Annex VI of the EU Cosmetics Regulation.”
BASF offers zinc oxide product line under its Z-Cote brand
BASF offers zinc oxide — with and without coating — under its Z-Cote brand. The product line can be used for all kinds of formulations from skin care and sun care to decorative cosmetics. Both Z-Cote grades cover nearly the whole UV spectrum from the short UVB to the long UVA-I (380nm) wavelengths. “Particulate UV filters such as Z-Cote absorb, reflect and scatter UV light, depending on the size of the particles: the smaller the size, the higher the absorption. Whereas the scattering improves protection — especially in the long UVA-I wavelengths,” said Mampe. Z-Cote is specifically recommended for daily skin care and also suitable for the sensitive skin of children and people with allergies.
Zinc oxide also approved for the use in cosmetics in the US
In the personal care industry, zinc oxide is known for decades for its beneficial properties as skin protectant and its antimicrobial activity. Zinc oxide is one of only two UV filters approved for UVA1 protection in sun care applications in the US. All Z-Cote filters show synergistic effects with organic UV filters and can be used to enhance the UVA and SPF performance of a sunscreen product.
Two more UV filters ready for EU approval
The whole BASF range of UV filters has been toxicologically assessed for their suitability in cosmetic preparations. Nevertheless, the use of nano UV filters to protect the skin is still subject to specific legislation in many countries. For Europe, the next microfine UV filter is ready for approval: In February 2016, titanium dioxide has received a positive vote by the EU Commission Working Group on Cosmetics. The official entry of the nano UV filter into Annex VI of the EU Cosmetics Regulation is expected for the second half of 2016. With Methylene Bis-Benzotriazolyl Tetramethylbutyl-phenol (MBBT) another nano UV filter is still on the voting list of the EU. MBBT is on the market under the BASF brand Tinosorb M since 2000, when it got the approval as UV ingredient. Since then, it has been used worldwide — except the US — in sunscreens from pharmacy to store brands. However, a new approval as "nano“ was required due to the new EU Cosmetics Regulation. In 2015, the Scientific Committee for Consumer Safety (SCCS) published a positive scientific opinion on MBBT in nano form. The official entry into Annex VI is anticipated for 2017.
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance